Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 3 (2006), Issue 12 (December)

1. The risk of pancreatic cancer in patients with gastric or duodenal ulcer disease.
   Int J Cancer, 120(2): 368-72. [Abstract] [Full-text]
2. Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells.
   Cancer Res, 66(23): 11131-9. [Abstract] [Full-text]
3. Expression and differential signaling of heregulins in pancreatic cancer cells.
   Int J Cancer, 120(3): 514-23. [Abstract] [Full-text]
4. Pancreaticoduodenectomy for suspected malignancy: have advancements in radiographic imaging improved results?
   Am J Surg, 192(6): 888-93. [Abstract] [Full-text]
5. Solid pseudopapillary tumor of the pancreas: a multicenter study of 23 pediatric cases.
   J Pediatr Surg, 41(12): 1992-5. [Abstract] [Full-text]
6. Laparoscopic versus open approach for solitary insulinoma.
   Surg Endosc, 21(1): 103-8. [Abstract] [Full-text]
7. Calpain facilitates actin reorganization during glucose-stimulated insulin secretion.
   Biochem Biophys Res Commun, 352(3): 650-5. [Abstract] [Full-text]
8. Fine-needle aspiration cytology of pancreatic lymphoepithelial cysts.
   Cancer, 108(6): 501-6. [Abstract] [Full-text]
9. Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility.
   Gut, 56(1): 95-106. [Abstract] [Full-text]
10. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.
    J Natl Cancer Inst, 98(24): 1806-18. [Abstract] [Full-text]
11. Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma.
    Cancer Chemother Pharmacol, 59(3): 361-7. [Abstract] [Full-text]
12. Phase I study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer.
    Int J Radiat Oncol Biol Phys, 67(1): 219-24. [Abstract] [Full-text]
13. Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer.
    Int J Radiat Oncol Biol Phys, 67(1): 211-8. [Abstract] [Full-text]
14. Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer model.
    Cancer Lett, 247(1): 143-9. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.